Condition

Obstructive Sleep Apnoea

ClinicalTrials.gov condition label

Clinical trials14

Recruiting2

Common interventions14

Lead sponsors shown9

Clinical trials

14 shown

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaNCT07571109 · 2026-05-05

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaNCT07571005 · 2026-05-05

Obstructive Sleep Apnoea in Patients With Type 1 DiabetesNCT03481361 · 2018-02-14

PAIR Study-PAP And IOP Relationship: Study 2NCT03145129 · 2017-03-24

PAIR Study-PAP And IOP Relationship: Study 1NCT03127813 · 2017-02-15

EndoBarrier in Obstructive Sleep Apnoea StudyNCT06376305 · 2016-03-01

Prevalence of Obstructive Sleep Apnoea in GlaucomaNCT02713152 · 2016-03-01

Leg Fluid Shift in Patients With Chronic Heart Failure and Obstructive or Central Sleep ApneaNCT03092388 · 2015-02-01

The SAD Study - SLEEP, ANXIETY & DEPRESSION Study A Prospective Cohort StudyNCT01985347 · 2013-11-01

Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep ApnoeaNCT01557166 · 2012-06-07

Peripheral Vascular Function in Obstructive Sleep ApnoeaNCT01619748 · 2012-06-01

Ambulatory Versus Home Blood Pressure Monitoring in Obstructive Sleep ApneaNCT01685736 · 2012-02-01

Obstructive Sleep Apnoea and Adipose Tissue DysfunctionNCT02518633 · 2010-03-01

Lifestyle Intervention in Obstructive Sleep ApnoeaNCT01546792 · 2010-01-01

Common interventions

NNC0487-0111DRUG2 Placebo (matched to NNC0487-0111)DRUG2 Application of continuous positive airway pressure (CPAP)OTHER1 Capillary Blood Gas Analysis (CBGA)DIAGNOSTIC_TEST1 Combined lifestyle interventionBEHAVIORAL1 Continuous Positive Airway PressureDEVICE1 Continuous positive airway pressure devicesDEVICE1 CPAPDEVICE1 EndoBarrierDEVICE1 liraglutideDRUG1 Multi Frequency Bioimpedance Analysis (mfBIA)DIAGNOSTIC_TEST1 placeboDRUG1 Polysomnography/Polygraphy (PSG/PG)DIAGNOSTIC_TEST1 Tilting Table with Hemodynamic MonitoringDIAGNOSTIC_TEST1

Leading sponsors

Novo Nordisk A/S3 Papworth Hospital NHS Foundation Trust3 Sheffield Teaching Hospitals NHS Foundation Trust2 Dr Bob Ryder1 Heart and Diabetes Center North-Rhine Westfalia1 Royal Devon and Exeter NHS Foundation Trust1 The Queen Elizabeth Hospital1 University of Athens1 University of Birmingham1

Trial status mix

COMPLETED9

RECRUITING2

UNKNOWN2

TERMINATED1

Phase mix

NA4

PHASE34

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.